FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutical industry, namely to a composition for treating degenerative joint diseases. Composition for treating degenerative diseases of joints, including multipotent mesenchymal stromal cells from adipose tissue (MMSC AT), "Linteks mesogel" gel, autoserum and physiological solution taken in effective amounts.
EFFECT: disclosed composition is effective for treating degenerative joint diseases.
8 cl, 3 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CARTILAGE HYALINE NEOGENESIS ACCOMPANYING EARLY DESTRUCTIVE DISEASES | 2010 |
|
RU2452527C1 |
METHOD FOR REPAIRING LONG BONE DEFECTS OF CRITICAL SIZE | 2013 |
|
RU2545993C2 |
MULTIPOTENT MESENCHYMAL STEM CELL CULTURE RECOVERED FROM BOVINE FATTY TISSUE (Medulla ossium Bos taurus) FOR PURPOSES OF VETERINARY SCIENCE, CELL AND TISSUE ENGINEERING | 2011 |
|
RU2482182C1 |
METHOD FOR RESTORING HYALINE CARTILAGE DEFECTS OF EXTREMITY ARTICULATING SURFACES | 2014 |
|
RU2559089C1 |
METHOD OF OBTAINING OF HYBRID HUMAN STEM CELL | 2007 |
|
RU2352637C1 |
BIO TRANSPLANT FOR THE JOINTS DYSPLASIA TREATMENT AND METHOD OF ITS PREPARATION | 2017 |
|
RU2659204C1 |
LINE OF MULTIPOTENT MESENCHYMAL STEM SELLS OF HUMAN SUBCUTANEOUS FATTY TISSUE (PANNICULUS ADIPOSUS HOMO SAPIENSE) FOR CELL AND TISSUE ENGINEERING | 2007 |
|
RU2354693C2 |
BIOTRANSPLANT AND METHOD FOR TREATING DEGENERATIVE AND TRAUMATIC DISEASES OF ARTICULAR CARTILAGE | 2003 |
|
RU2242981C1 |
BIOTRANSPLANT FOR TREATMENT OF DEGENERATIVE AND TRAUMATIC DISEASE OF CARTILAGE TISSUE AND METHOD FOR ITS PREPARING | 2005 |
|
RU2301677C1 |
METHOD OF TREATMENT OF FULL-LAYER DEFECTS OF KNEE JOINT CARTILAGE WITH USE OF AUTOLOGOUS MESENCHYMAL STEM CELLS CULTURE | 2007 |
|
RU2351020C1 |
Authors
Dates
2019-12-06—Published
2018-12-12—Filed